Oxigene Inc (NASDAQ:OXGN)

CAPS Rating: 2 out of 5

A biotechnology company developing novel small-molecule therapeutics to treat cancer and eye diseases.

Recs

1
Player Avatar siri22 (< 20) Submitted: 11/17/2011 8:02:08 AM : Outperform Start Price: $12.00 OXGN Score: +9.93

I own it wish I never bought. So sit and hope!

Featured Broker Partners


Advertisement